Approval for the addition of the antibiotic ofloxacin at concentrations of 1, 2 and 4 micrograms/ml to the vitek(r) 2 s. pneumoniae susceptibility test system.  The device, as modified, will be marketed under the trade name vitek(r) 2 s. pneumoniae susceptibility test cards for use in the vitek 2 system and is indicated for use for the susceptibility testing of streptococcus pneumoniae to ofloxacin in the range of <-1 to >=8 micrograms/ml.